BEVITAL AS

Targeted Metabolomics Services

PAr index

B6
Updated 21/12/2022

What is PAr index?

PAr index is the ratio of 4-pyridoxic acid divided by the sum of pyridoxal 5´-phosphate plus pyridoxal (PA:(PLP+PL)). Inflammatory markers account for more than 90 % of the explained variance of PAr, which efficiently discriminates subjects with high inflammatory status. It is only slightly influenced by vitamin B6 intake and reflects increased vitamin B6 catabolism during inflammation (2, 3).
Method: LC-MS/MS

Indication(s)

Assessment of vitamin B6 catabolism during inflammation. PAr should be regarded as a marker of inflammation.

Specimen, collection and processing

Patient/subject: PAr is essentially not influenced by vitamin B6 intake, and only moderately affected by supplementation with high doses of pyridoxine.
Matrix: EDTA plasma and serum.
Volume: Minimum volume is 60 µL, but 200 µL is optimal and allows reanalysis.
Preparation and stability: See separate B6 vitamers. The PAr index is essentially not influenced by the conversion of PLP to PL that occurs during non-optimal handling of serum samples. The blood sample must be centrifuged and the plasma/serum fraction put on ice, and frozen.

Transportation

Frozen, on dry ice. (for general instruction on transportation, click here)

Reported values, interpretation

Reported values: 0.29-0.51.
Intraclass correlation coefficients (ICC): 0.75.

Literature

1. Midttun, O., Hustad, S., and Ueland, P.M. (2009). Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Sp 23, 1371-79.
2. Ulvik, A., Midttun, O., Pedersen, E.R., Eussen, S.J., Nygård, O., and Ueland, P.M. (2014). Evidence for increased catabolism of vitamin B-6 during systemic inflammation. Am J Clin Nutr 100, 250-55.
3. Ueland, P. M., A. McCann, O. Midttun and A. Ulvik (2017) Inflammation, vitamin B6 and related pathways. Mol Aspects Med 53:10-27.

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more

Scroll to Top

Join our Mailing list!

Get updates of our latest articles, events and method developments.

Join our Mailing list!

Get updates of our latest articles, events and method developments.